6-Phosphogluconate dehydrogenase (6PGD), a key checkpoint in reprogramming of regulatory T cells metabolism and function

Cellular metabolism has key roles in T cells differentiation and function. CD4+ T helper-1 (Th1), Th2, and Th17 subsets are highly glycolytic while regulatory T cells (Tregs) use glucose during expansion but rely on fatty acid oxidation for function. Upon uptake, glucose can enter pentose phosphate...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Saeed Daneshmandi, Teresa Cassel, Richard M Higashi, Teresa W-M Fan, Pankaj Seth
Formato: article
Lenguaje:EN
Publicado: eLife Sciences Publications Ltd 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/851c6bd2a26549a4b642403b49029a4d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:851c6bd2a26549a4b642403b49029a4d
record_format dspace
spelling oai:doaj.org-article:851c6bd2a26549a4b642403b49029a4d2021-11-15T06:05:32Z6-Phosphogluconate dehydrogenase (6PGD), a key checkpoint in reprogramming of regulatory T cells metabolism and function10.7554/eLife.674762050-084Xe67476https://doaj.org/article/851c6bd2a26549a4b642403b49029a4d2021-10-01T00:00:00Zhttps://elifesciences.org/articles/67476https://doaj.org/toc/2050-084XCellular metabolism has key roles in T cells differentiation and function. CD4+ T helper-1 (Th1), Th2, and Th17 subsets are highly glycolytic while regulatory T cells (Tregs) use glucose during expansion but rely on fatty acid oxidation for function. Upon uptake, glucose can enter pentose phosphate pathway (PPP) or be used in glycolysis. Here, we showed that blocking 6-phosphogluconate dehydrogenase (6PGD) in the oxidative PPP resulted in substantial reduction of Tregs suppressive function and shifts toward Th1, Th2, and Th17 phenotypes which led to the development of fetal inflammatory disorder in mice model. These in turn improved anti-tumor responses and worsened the outcomes of colitis model. Metabolically, 6PGD blocked Tregs showed improved glycolysis and enhanced non-oxidative PPP to support nucleotide biosynthesis. These results uncover critical role of 6PGD in modulating Tregs plasticity and function, which qualifies it as a novel metabolic checkpoint for immunotherapy applications.Saeed DaneshmandiTeresa CasselRichard M HigashiTeresa W-M FanPankaj SetheLife Sciences Publications Ltdarticleregulatory T cellmetabolism6PGDimmunoregulationglucosepentose phosphate pathwayMedicineRScienceQBiology (General)QH301-705.5ENeLife, Vol 10 (2021)
institution DOAJ
collection DOAJ
language EN
topic regulatory T cell
metabolism
6PGD
immunoregulation
glucose
pentose phosphate pathway
Medicine
R
Science
Q
Biology (General)
QH301-705.5
spellingShingle regulatory T cell
metabolism
6PGD
immunoregulation
glucose
pentose phosphate pathway
Medicine
R
Science
Q
Biology (General)
QH301-705.5
Saeed Daneshmandi
Teresa Cassel
Richard M Higashi
Teresa W-M Fan
Pankaj Seth
6-Phosphogluconate dehydrogenase (6PGD), a key checkpoint in reprogramming of regulatory T cells metabolism and function
description Cellular metabolism has key roles in T cells differentiation and function. CD4+ T helper-1 (Th1), Th2, and Th17 subsets are highly glycolytic while regulatory T cells (Tregs) use glucose during expansion but rely on fatty acid oxidation for function. Upon uptake, glucose can enter pentose phosphate pathway (PPP) or be used in glycolysis. Here, we showed that blocking 6-phosphogluconate dehydrogenase (6PGD) in the oxidative PPP resulted in substantial reduction of Tregs suppressive function and shifts toward Th1, Th2, and Th17 phenotypes which led to the development of fetal inflammatory disorder in mice model. These in turn improved anti-tumor responses and worsened the outcomes of colitis model. Metabolically, 6PGD blocked Tregs showed improved glycolysis and enhanced non-oxidative PPP to support nucleotide biosynthesis. These results uncover critical role of 6PGD in modulating Tregs plasticity and function, which qualifies it as a novel metabolic checkpoint for immunotherapy applications.
format article
author Saeed Daneshmandi
Teresa Cassel
Richard M Higashi
Teresa W-M Fan
Pankaj Seth
author_facet Saeed Daneshmandi
Teresa Cassel
Richard M Higashi
Teresa W-M Fan
Pankaj Seth
author_sort Saeed Daneshmandi
title 6-Phosphogluconate dehydrogenase (6PGD), a key checkpoint in reprogramming of regulatory T cells metabolism and function
title_short 6-Phosphogluconate dehydrogenase (6PGD), a key checkpoint in reprogramming of regulatory T cells metabolism and function
title_full 6-Phosphogluconate dehydrogenase (6PGD), a key checkpoint in reprogramming of regulatory T cells metabolism and function
title_fullStr 6-Phosphogluconate dehydrogenase (6PGD), a key checkpoint in reprogramming of regulatory T cells metabolism and function
title_full_unstemmed 6-Phosphogluconate dehydrogenase (6PGD), a key checkpoint in reprogramming of regulatory T cells metabolism and function
title_sort 6-phosphogluconate dehydrogenase (6pgd), a key checkpoint in reprogramming of regulatory t cells metabolism and function
publisher eLife Sciences Publications Ltd
publishDate 2021
url https://doaj.org/article/851c6bd2a26549a4b642403b49029a4d
work_keys_str_mv AT saeeddaneshmandi 6phosphogluconatedehydrogenase6pgdakeycheckpointinreprogrammingofregulatorytcellsmetabolismandfunction
AT teresacassel 6phosphogluconatedehydrogenase6pgdakeycheckpointinreprogrammingofregulatorytcellsmetabolismandfunction
AT richardmhigashi 6phosphogluconatedehydrogenase6pgdakeycheckpointinreprogrammingofregulatorytcellsmetabolismandfunction
AT teresawmfan 6phosphogluconatedehydrogenase6pgdakeycheckpointinreprogrammingofregulatorytcellsmetabolismandfunction
AT pankajseth 6phosphogluconatedehydrogenase6pgdakeycheckpointinreprogrammingofregulatorytcellsmetabolismandfunction
_version_ 1718428563422576640